Physician profile

Alan M Harben

Pain Medicine (Physical Medicine & Rehabilitation) · Roswell, GA

NPI 1669652095

$6,063.00

in general payments reported to CMS, 2019-2025

36 companies · $849 in 2025

The $849 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,326.05

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,315.14 2021-2025
Neurocrine Biosciences, INC. $690.87 2019-2025 Ingrezza
Teva Pharmaceuticals USA, INC. $687.52 2019-2025 Austedo Xr, Austedo Xr, Ajovy
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $552.93 2021-2025 Caplyta
Otsuka America Pharmaceutical, INC. $546.69 2019-2025 Rexulti, Abilify Maintena
Lundbeck LLC $238.08 2021-2025 Vyepti, Rexulti
Pfizer INC. $223.78 2020-2025
Avanir Pharmaceuticals, INC. $188.87 2019-2021
Axsome Therapeutics, INC. $178.86 2023-2025 Auvelity
Takeda Pharmaceuticals U.S.A., INC. $146.89 2019-2022
Allergan, INC. $137.11 2020-2022
Averitas Pharma INC. $126.47 2024-2025 Qutenza
Mdd US Operations, LLC $111.69 2024 Gocovri
Eisai INC. $107.15 2021-2022
Currax Pharmaceuticals LLC $101.14 2020-2021
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Merz North America, INC. $89.64 2019
Arbor Pharmaceuticals, INC. $75.65 2019-2022
Merck Sharp & Dohme LLC $61.57 2020-2023 Belsomra
Dynasplint Systems INC. $52.36 2021
Biohaven Pharmaceuticals, INC. $45.79 2021
Ibsa Pharma INC. $45.10 2021
Amgen INC. $43.60 2019
Merz Pharmaceuticals, LLC $41.15 2022
Novartis Pharmaceuticals Corporation $35.13 2021
Idorsia Pharmaceuticals US INC $30.17 2023-2024 Quviviq
Tersera Therapeutics LLC $27.17 2023 Prialt
Collegium Pharmaceutical, INC. $20.06 2019
Spr Therapeutics, INC $19.55 2024 Sprint Pns System
Vertical Pharmaceuticals, LLC $18.89 2019
Saol Therapeutics INC. $18.15 2019
Azurity Pharmaceuticals, INC. $17.76 2025 Edarbi
Impel Pharmaceuticals INC. $16.73 2022
Microtransponder, INC. $14.38 2025
E.R. Squibb & Sons, L.L.C. $13.55 2021
Redhill Biopharma INC. $12.05 2020
Ipsen Biopharmaceuticals, INC $11.36 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alan M Harben

$6,063.00

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $849 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).

https://glasscript.com/doctor/302156/alan-m-harben

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.